Contact Details
Home
About CuroVax
Company Profile
Company Culture
Factory Snapshots
Products & Services
Vaccine
Logistics Distribution
Information Disclosure
Adverse Reaction
Policy & News
Policies and regulations
Industry News
Company News
R&D & Innovation
R&D Platform
Products in Development
Quality Control
Quality Management System
Join Us
Recruitment
Contact
Language
中文
English
2023-04-27
NDA submission for "Lyophilised Human Rabies Vaccine (Vero Cell)" project was accepted.
The project of "Tetravalent Influenza Virus Lysate Vaccine" was approved for clinical trial.
Next
2019
Fax：0519-81668927 Email：contact@curovax.net
[Follow public number]
State Drug Administration (SDA)
China Institute for Food and Drug Control (CIFDC)
Chinese Centre for Disease Control and Prevention (CDC)
WHO
NIBSC
ATCC
Jiangsu Provincial Drug Administration
©2023 Jiangsu CuroVax Co., Ltd IPV6 Powered by www.300.cn | tabs
